Tevogen Bio taps award-winning oncologist to lead R&D
Tevogen Bio appointed Dr. Neal Flomenberg as chief scientific officer and global head of research and development.
Source: njbiz.com
Page 41 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Today - Breaking & Trending Today
Hospice or 'All Care Possible'? Answer May Be Shaped by Race
The healthcare that patients with dementia receive in the last 180 days of life may look substantially different when patients are grouped by race or ethnicity.
Source: medscape.com
When Is Chemo Not Appropriate?
Providing chemotherapy in the hospital setting can be harmful in some scenarios.
Source: medscape.com
Breyanzi Approved as Second-Line Treatment for Large B-Cell Lymphoma
The FDA has approved Breyanzi (lisocabtagene maraleucel) for adults with relapsed or refractory large B-cell lymphoma after 1 prior therapy.
Source: empr.com
How FDA Is Working to Improve Oncology Drug Development
The US Food and Drug Administration is working with pharma to reform the accelerated approval process, introduce novel drugs to earlier therapy lines, and make trials more accessible.
Source: medscape.com